Matthew DurhamOmnidynamic Marketing
Daniel SontupeMarket Access
Matt TurnerPatient Affordability
Suma Ramadas, PhDMedical Affairs
Brenda SnowAuthentic Patient Voice
Amy GilesIncreasing Engagement
Pat PurcellMeeting Engagement
Liz KaneImpactful Strategy
Joey CohenMedication Adherence
Stacey GandlerBrand Nourishment
Frank BurrellScientific Storytelling
Bud BilanichSuccess Coach
Paul TheisenPatient Acquisition
David LinetskyPoint-of-Care Marketing
Exclusive worldwide license to lentiviral vector gene therapy constitutes the first transaction of Axovant’s ...
Username
Email
Password
Confirm Password
Remember Me
Username or Email